Dr. Schumacher is a serial entrepreneur, author, futurologist, and Co-Founder of HLTH Network, a global tech company at the forefront of digital health and data tokenization. Axel has over 30 years’ experience in the fields of Longevity, Genetics, Digital Health, Epigenomics, Biomarkers, Biobanking, Precision Medicine, Crypto, Pharma R&D, with additional expertise in Content Marketing, Game Theory, Business Strategy, Technology Development, Strategic Innovation, and Drug Development. Axel is a board advisor in two stealth startups and co-founded three research organizations, among them a large international pandemic preparedness consortium. Axel is the author of the “Blockchain & Healthcare Strategy Guide”, a ‘must-read’ for decision makers in the digital healthcare vertical. Axel is particularly well known for his work in epigenetics. He invented the first microarray technologies for epigenetic biomarker discovery that eventually led to the discovery of 'epigenetic clocks', developed the ‘epigenetic theory of ageing’ with his research leading to the worldwide first proof of whole genome epigenetic abnormalities in Alzheimer's disease. Axel is also a member of the Blockchain Research Institute in Toronto, the world’s leading Blockchain Think Tank. Axel developed business models in the field of blockchain technology, microarray technology, IV therapies, artificial intelligence, microfluidics, genomics, cryptocurrencies, tokenomics, mobile apps, epigenomics, medical cannabis, online dating, fitness/wellness & animal genetics. Axel’s mission is to translate scientific discoveries into practical digital applications to help understand and prevent complex disorders, and to transform the way we age. He holds a Ph.D. in Human Genetics from the University of Cologne/Germany.